Average Co-Inventor Count = 4.63
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boston University (13 from 818 patents)
2. Northeastern University (2 from 757 patents)
3. Boston Medical Center Corporation (2 from 61 patents)
4. University of California (1 from 15,475 patents)
5. Fundacao Oswaldo Cruz (1 from 24 patents)
13 patents:
1. 12251372 - Antileishmanial compounds, compositions and use thereof
2. 11458132 - Quinolin-2(1H)-one inhibitors of Late SV40 Factor
3. 11420977 - Late SV40 (LSF) inhibitors
4. 11242353 - Heterocyclic LSF inhibitors and their uses
5. 10392398 - Inhibitors of Late SV40 Factor (LSF) as cancer chemotherapeutics
6. 10314810 - Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics
7. 10258600 - Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics
8. 9815845 - Inhibitors of late SV40 factor (LSF) as cancer chemotherapeutics
9. 9802948 - Inhibitors of late SV40 factor (LSF) as cancer chemotherapeutics
10. 9597325 - Inhibitors of late SV40 factor (LSF) as cancer chemotherapeutics
11. 9567331 - Pyridopyrimidinone inhibitors of viruses
12. 9399644 - [1,3] dioxolo [4,5-G] quinoline-6(5H)thione derivatives as inhibitors of the late SV40 factor (LSF) for use in treating cancer
13. 9175001 - [1,3] dioxolo [4,5-g] [1,2,4] triazolo [1,5-a] quinoline derivatives as inhibitors of the late SV40 factor (LSF) for use in treating cancer